{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:19:08Z","timestamp":1782973148692,"version":"3.54.5"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>T-cell depleted (TCD) haploidentical transplantation using CD3+\/CD19+ and TCR\u03b1\u03b2+\/CD19+ depletion techniques has been increasingly used in children with hematological malignancies. We present a retrospective study aimed to compare transplant outcomes in children with leukemia receiving a TCD haploidentical transplant using either CD3+\/CD19+ or TCR\u03b1\u03b2+\/CD19+ platforms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 159 children with leukemia (ALL=80) (AML=79) that received a TCD haploidentical transplantation using either CD3+\/CD19+ (n=79) or TCR\u03b1\u03b2+\/CD19+ (n=80) platforms between 2005 and 2020 were included. Median age was 9 years in both groups. There were no differences in patient, donor, and transplant characteristics between groups except for donor KIR B genotype more frequent in the TCR\u03b1\u03b2+\/CD19+ group (91%) than in the CD3+\/CD19+ group (76%) (p=0.009) and a high number of NK+ cells and lower CD19+ cells infused in the TCR\u03b1\u03b2+\/CD19+ group (35.32x10<jats:sup>6<\/jats:sup>\/kg and 0.06 x10<jats:sup>6<\/jats:sup>\/Kg) than in the CD3+\/CD19 group (24.6x10<jats:sup>6<\/jats:sup>\/Kg and 0.25 x10<jats:sup>6<\/jats:sup>\/Kg) (p=0.04 and p=0.0001), respectively. Conditioning was based on TBF. Median follow-up for survivors was 11 years (range; 8-16 y) in CD3+\/CD19+ group and 5 years (range; 2-9 y) in the TCR\u03b1\u03b2+\/CD19+ group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Engraftment kinetics were similar in both groups (13 days for neutrophils and 10 days for platelets). There was no difference in the incidence of acute GvHD II-IV (29 \u00b1 5% in the CD3+\/CD19+ group vs 38 \u00b1 5% in the TCR\u03b1\u03b2+\/CD19+ group) and chronic GvHD (32 \u00b1 5% vs 23 \u00b1 4%, respectively). NRM was 23 \u00b1 5% in the CD3+\/CD19+group vs 21 \u00b1 4% in the TCR\u03b1\u03b2+\/CD19+group. Relapse incidence was also similar, 32 \u00b1 5% vs 34 \u00b1 6%, respectively. DFS and OS were not different (45 \u00b1 5% vs 45 \u00b1 6% and 53 \u00b1 6% vs 58 \u00b1 6% respectively). As there were no differences on transplant outcomes between groups, we further analyzed all patients together for risk factors associated with transplant outcomes. On multivariate analysis, we identified that early disease status at transplant (HR: 0.16; 95%CI (0.07-0.35) (p=0.0001), presence of cGvHD (HR: 0.38; 95%CI (0.20-0.70) (p= 0.002), and donor KIR-B genotype (HR: 0.50; 95%CI (0.32-0.90) (p=0.04) were associated with better DFS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our data suggest that there are no advantages in transplant outcomes between TCD platforms. Risk factors for survival are dependent on disease characteristic, donor KIR genotype, and chronic GvHD rather than the TCD platform used.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.884397","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T02:08:11Z","timestamp":1655690891000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["T-Cell Depleted Haploidentical Transplantation in Children With Hematological Malignancies: A Comparison Between CD3+\/CD19+ and TCR\u03b1\u03b2+\/CD19+ Depletion Platforms"],"prefix":"10.3389","volume":"12","author":[{"given":"Marta","family":"Gonzalez-Vicent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josune","family":"Zubicaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Vicario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sebasti\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Iriondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorea","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2014.10.001","article-title":"Hematopoietic Cell Transplantation and Cellular Therapeutics in the Treatment of Childhood Malignancies","volume":"62","author":"Mallhi","year":"2015","journal-title":"Pediatr Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbmt.2007.10.007","article-title":"Alternative Allogeneic Donor Sources for Transplantation for Childhood Diseases: Unrelated Cord Blood and Haploidentical Family Donors","volume":"14","author":"Cairo","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA Match Likelihoods for Hematopoietic Stem - Cell Grafts in the U.S. Registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705963","article-title":"Searching for Alternative Hematopoietic Stem Cell Donors for Pediatric Patients","volume":"41","author":"Rocha","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-514760","article-title":"Hematopoietic Stem Cell Transplantation Donor Sources in the 21st Century: Choosing the Ideal Donor When a Perfect Match Does Not Exist","volume":"124","author":"Kekre","year":"2014","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of High-Risk Acute Leukemia With T-Cell-Depleted Stem Cells From Related Donors With One Fully Mismatched HLA Haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.20","article-title":"Hematopoietic Stem Cell Transplantation in Europe 2014: More Than 40000 Transplants Annually","volume":"51","author":"Passweg","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.04.018","article-title":"Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer Between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report","volume":"23","author":"Khandelwal","year":"2017","journal-title":"BBMT"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(03)00063-8","article-title":"Haploidentical Transplantation for Acute Lymphoblastic Leukemia in Childhood","volume":"18","author":"Klingebiel","year":"2004","journal-title":"Blood Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06300.x","article-title":"Current Status of Haploidentical Stem Cell Transplantation","volume":"135","author":"Dey","year":"2006","journal-title":"Br J Haematol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-338822","article-title":"Haploidentical Hematopoietic Transplantation: Current Status and Future Perspectives","volume":"118","author":"Reisner","year":"2011","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/CCO.0000000000000480","article-title":"Allogeneic Hematopoietic Stem-Cell Transplantation From Haploidentical Donors Using \u2018Ex-Vivo\u2019 T-Cell Depletion in Pediatric Patients With Hematological Malignancies: State of the Art Review","volume":"30","author":"Gonzalez-Vicent","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.101","article-title":"Prognostic Factors and Outcomes for Pediatric Patients Receiving an Haploidentical Related Allogeneic Transplantation Using CD3\/CD19-Depleted Grafts","volume":"51","author":"Diaz","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181cf813c","article-title":"Graft Manipulation and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation From Mismatched Unrelated and Mismatched\/Haploidentical Related Donors in Pediatric Leukemia Patients","volume":"32","author":"Gonzalez-Vicent","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02504","article-title":"Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using \u03b1\u03b2+T-Cell Receptor and CD19+ Cell Depleted Grafts: High CD56dim\/CD56bright NK Cell Ratio Early Following Transplantation Is Associated With Lower Relapse Incidence and Better Outcome","volume":"10","author":"Diaz","year":"2019","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow Antibody Panels for Standardized N-Dimensional Flow Cytometric Immunophenotyping of Normal, Reactive and Malignant Leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2004.03.018","article-title":"Comparative Genomic Analysis, Diversity and Evolution of Two KIR Haplotypes A and B","volume":"335","author":"Martin","year":"2004","journal-title":"Gene"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302517","article-title":"Donor Killer-Cell Immunoglobulin-Like Receptor Haplotypes, Recipient HLA-C1 and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia","volume":"192","author":"Cooley","year":"2014","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2017.03.001","article-title":"Donor Age Matters in T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients: Faster Immune Reconstitution Using Younger Donors","volume":"57","author":"Gonz\u00e1lez-Vicent","year":"2017","journal-title":"Leukemia Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1600-0609.2011.01627.x","article-title":"Allogeneic Hematopoietic Transplantation Using Haploidentical Donor vs. Unrelated Cord Blood Donor in Pediatric Patients: A Single-Center Retrospective Study","volume":"87","author":"Gonzalez-Vicent","year":"2011","journal-title":"Eur J Haematol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.196.3018","article-title":"Graft Failure After \u2018Ex-Vivo\u2019 T-Cell Depleted Haploidentical Transplantation in Pediatric Patients With High-Risk Hematological Malignancies. A Risk Factors and Outcomes Analysis","volume":"62","author":"D\u00edaz","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"B22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical Manifestations of Graft-Versus-Host Disease in Human Recipients of Marrow From HL-A-Matched Sibling Donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: I. Diagnosis and Staging Working Group Report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2008.02.008","article-title":"Diagnosis and Manifestations of Chronic Graft-Versus-Host Disease","volume":"21","author":"Filipovich","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.43","article-title":"Early Evaluation of Immune Reconstitution Following Allogeneic CD3\/CD19-Depleted Grafts From Alternative Donors in Childhood Acute Leukemia","volume":"47","author":"P\u00e9rez-Mart\u00ednez","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176350951","article-title":"A Class of K-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk","volume":"16","author":"Gray","year":"1988","journal-title":"Am Stat"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.359","article-title":"Regression Modeling of Competing Risk Using R: A in Depth Guide for Clinicians","volume":"45","author":"Scrucca","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01246-5","article-title":"Contemporary Haploidentical Stem Cell Transplant Strategies in Children With Hematological Malignancies","volume":"56","author":"Shah","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/ejh.13636","article-title":"\u201cEx-Vivo\u201d T-Cell Depletion in Allogeneic Hematopoietic Stem Cell Transplantation. New Clinical Approaches for Old Challenges","volume":"107","author":"Diaz","year":"2021","journal-title":"Eur J Haematol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of Children With Acute Leukemia Given HLA-Haploidentical HSCT After \u03b1\u03b2 T-Cell and B-Cell Depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00047-2","article-title":"ATG in Paediatric Haemopoietic Stem Cell Transplantation","volume":"2","author":"Diaz","year":"2015","journal-title":"Lancet Haematol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.18618","article-title":"Defibrotide in Hematopoietic Stem Cell Transplantation: A Multicenter Survey Study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)","volume":"106","author":"Gonzalez Vicent","year":"2021","journal-title":"Eur J Haematol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.07.016","article-title":"Unexpected High Incidence of HHV-6 Encephalitis After Naive T Cell-Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric Patients","volume":"24","author":"Sisini","year":"2018","journal-title":"BBMT"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.07.033","article-title":"High Incidence of Early Human Herpesvirus-6 Infection in Children Undergoing Haploidentical Manipulated Stem Cell Transplantation for Hematologic Malignancies","volume":"24","author":"Perruccio","year":"2018","journal-title":"BBMT"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.4.1303","article-title":"Infection of \u03b3\u03b4 T Lymphocytes by Human Herpesvirus 6: Transcriptional Induction of CD4 and Susceptibility to HIV Infection","volume":"181","author":"Lusso","year":"1995","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082187","article-title":"Phenotypic and Functional Characterization of NK Cells in \u03b1\u03b2+T-Cell Receptor and B-Cell Depleted Haplo-HSCT to Cure Pediatric Patients With Acute Leukemia","volume":"12","author":"Meazza","year":"2020","journal-title":"Cancers"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.235","article-title":"Immune Reconstitution After Haploidentical Hematopoietic Cell Transplantation: Impact of Reduced Intensity Conditioning and CD3\/CD19 Depleted Grafts","volume":"25","author":"Federmann","year":"2011","journal-title":"Leukemia"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17563","article-title":"Incidence and Impact of Community Respiratory Viral Infections in Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis and Haploidentical Stem Cell Transplantation","volume":"194","author":"Mulroney","year":"2021","journal-title":"Br J Haematol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009362","article-title":"Posttransplant Cyclophosphamide Is Associated With Increased Cytomegalovirus Infection: A CIBMTR Analysis","volume":"137","author":"Goldsmith","year":"2021","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00147","article-title":"Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation","volume":"11","author":"Rovatti","year":"2020","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2018.04.009","article-title":"NK Cells Mediate a Crucial Graft-Versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia","volume":"39","author":"Locatelli","year":"2018","journal-title":"Trends Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25661","article-title":"Haploidentical Transplantation in High-Risk Pediatric Leukemia: A Retrospective Comparative Analysis on Behalf of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON) and the Spanish Grupo for Hematopoietic Transplantation (GETH)","volume":"95","author":"Perez-Martinez","year":"2020","journal-title":"Am J Hematol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01259-0","article-title":"Natural Killer Cell Alloreactivity in HLA-Haploidentical Hematopoietic Transplantation: A Study on Behalf of the CTIWP of the EBMT","volume":"56","author":"Ruggeri","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003739","article-title":"Haploidentical Age-Adapted Myeloablative Transplant and Regulatory and Effector T Cells for Acute Myeloid Leukemia","volume":"5","author":"Pierini","year":"2021","journal-title":"Blood Adv"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2011.60","article-title":"New Strategies for Haploidentical Transplantation","volume":"71","author":"Oevermann","year":"2012","journal-title":"Pediatr Res"}],"updated-by":[{"DOI":"10.3389\/fonc.2025.1680867","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.884397\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:40:16Z","timestamp":1758631216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.884397\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":45,"alternative-id":["10.3389\/fonc.2022.884397"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.884397","relation":{"correction":[{"id-type":"doi","id":"10.3389\/fonc.2025.1680867","asserted-by":"object"}]},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"article-number":"884397"}}